Despite large numbers of patients accessing antiretroviral treatment (ART) in Kenya, few studies have explored factors associated with virologic failure in Western Kenya, specifically. We undertook a study in Homa Bay County, Kenya to assess the extent of virologic treatment failure and factors associated with it. This was an observational retrospective study conducted from September 2020 to January 2021. Data were abstracted from the records of patients who had been on ART for at least six months at the time of data collection after systematic sampling stratified by age group at ART initiation (0–14 and 15+ years), using probability proportion to the numbers of patients attending the facility. Confirmed viral treatment failure was defined as viral load >1000 copies/ml based on two consecutive viral load measurements after at least three months of enhanced adherence counseling. Data were analyzed using descriptive statistics and Cox regression modeling. Of the 2,007 patients sampled, 160 (8.0%) had confirmed virologic treatment failure. Significantly higher virologic treatment failure rates were identified among male patients 78/830 (9.4%) and children 115/782 (14.7%). Factors associated with virologic treatment failure (VTF), were age 0–14 years, adjusted hazard ratio (AHR) 4.42, (95% Confidence Interval [CI], 3.12, 6.32), experience of treatment side effects AHD: 2.43, (95% CI, 1.76, 3.37), attending level 2/3 health facility, AHR: 1.87, (95% CI: 1.29, 2,72), and history of opportunistic infections (OIs), AHR: 1.81, (95% CI, 1.76, 3.37). Children, attendees of level 2/3 health facilities, patients with a history of OIs, and those experiencing treatment side effects are at risk of VTF. Increased focus on children and adolescents on screening for drug resistance, administration of and adherence to medication, and on effective information and education on side-effects is critical. Additionally, there is need for increased training and support for health care workers at primary level care facilities.
Explore Related Resources
Issue Briefs
PEPFAR: It Began With Children
Published November 2026
How it Started: Protecting Mothers and Babies In 2002, about 720,000 babies acquired HIV during pregnancy, delivery, or breastfeeding, which is known as mother-to-child or vertical transmission. The consequences were deadly: without treatment, half of children living with HIV died before their second birthday. Providing antiretroviral therapy (ART) and access to support services to women […]
View Resource
Topics:
Advocacy,
Prevention of Mother-to-Child Transmission (PMTCT)
Countries:
United States
Issue Briefs
Common Ground for Global Health Policy Brief: Mother-Baby Pair
Published November 2026
Introduction Within global health, the interconnected needs of mothers and children throughout pregnancy, labor, delivery, and the postpartum period are widely recognized; however, healthcare services are rarely designed or delivered with the mother-baby pair as a single unit of care. The mother-baby pair is key to improving maternal and child health outcomes, and vitally important […]
View Resource
Topics:
Advocacy,
HIV,
Maternal and Child Health,
Prevention of Mother-to-Child Transmission (PMTCT)
Countries:
Global
Journal Articles
Impact of a phased transition model on Advanced HIV Disease outcomes: A pre- and post-implementation evaluation study in Malawi
Published October 2026
A study from Malawi showed that transitioning AHD services to MoH leadership was associated with sustained key program outcomes and a significant reduction in mortality.
View Resource
Topics:
Advanced HIV Disease (AHD),
Technical Assistance
Countries:
Malawi